BARDA releases 2011-2016 strategic plan

The Biomedical Advanced Research and Development Authority, a part of the U.S. Department of Health and Human Services, released the "BARDA Strategic Plan 2011-2016" this week, which includes the authority's upcoming vision, guiding principles and goals.
The plan cites five major goals, including the development of an advanced pipeline of medical countermeasures and platforms to address unmet public health needs and long-term sustainability. Another goal is the build a capability base to provide the enablement of core services to the innovators of medical countermeasures.
"The plan describes our strategic goals and vision to accomplish BARDA’s mission over the next five years and beyond to develop and provide medical countermeasures for chemical, biological, radiological, and nuclear threats, pandemic influ­enza, and emerging infectious diseases," Robin A. Robinson, the director of BARDA, wrote in the plan's introduction. "The implementation measures to achieve these strategic goals include support of product advanced development, stockpile acquisition, manufacturing surge capacity infrastructure building, and product innovation. These medical countermeasures include vaccines, biological and small mol­ecule therapeutics, antiviral drugs and antibiotics, diagnostics, respiratory devices, and other medical supplies."
The other three main goals over the next five years are to create an agile, robust and sustainable U.S. manufacturing infrastructure that is able to rapidly produce vaccines and other biologics against pandemic influenza and other emerging threats, to create responsible and nimble programs and capabilities to address novel and emerging threats, and to have a ready capability to develop, manufacture and facilitate distribution of medical countermeasures during public health emergencies.
BARDA was created in 2007 in an effort to develop and procure medical countermeasures addressing the medical and public health consequences of chemical, biological, radiological and nuclear accidents, attacks and incidents, pandemic influenza and emerging infectious diseases.
"The BARDA Strategic Plan is a dynamic process with the steadfast aim to enhance national MCM preparedness and the flexibility to adopt better technologies, meet unforeseen challenges, and avoid unnecessary risks," Robinson wrote. "MCM preparedness and response and this Plan are the results of the dedicated professionals at BARDA, ASPR, and across federal, State, local, and industry sectors. I wish to thank them for their tireless efforts to ensure that ours is 'a nation prepared.'"